STAGE IIIB LUNG CANCER AJCC V8
Clinical trials for STAGE IIIB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation and new drug combo tested to fight spreading cancers
Disease control TerminatedThis early-phase trial tested the safety and initial effectiveness of a new immunotherapy drug (BMS-986218), given alone or with another immunotherapy drug (nivolumab), alongside targeted radiation therapy. It was for adults with advanced solid cancers that had spread to other pa…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New combo therapy tested for Tough-to-Treat lung cancer
Disease control TerminatedThis study tested whether adding an immunotherapy drug called bintrafusp alfa to standard chemotherapy (docetaxel) could better control advanced non-small cell lung cancer in patients whose cancer had worsened despite previous treatment with immunotherapy and chemo. The trial aim…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC